Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DLBS3233

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Polycystic ovary syndrome (PCOS) is known to be associated with insulin resistance and anti-Mullerian hormone (AMH… Expand
  • figure 2
  • figure 1
  • table 1
  • table 3
  • table 2
Is this relevant?
2017
2017
Simultaneous micronization and purification of DLBS3233 bioactive fraction, a combination of two Indonesian herbals Lagerstroemia… Expand
Is this relevant?
2016
2016
Background The aim of this paper is to evaluate the efficacy and safety of DLBS3233, a novel bioactive fraction derived from… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2016
2016
ABSTRACT Objective: DLBS3233, a new insulin sensitizing agent for Type 2 diabetes, is a combination-bioactive-fraction derived… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
Abstract Background DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, has preclinically… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
2016
2016
Objective: DLBS3233 is a standardized extract combination containing Lagerstroemia speciosa and Cinnamomum burmannii . The effect… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2012
2012
DLBS3233 is a standardized extract combination of two Indonesian herbals (Lagerstroemia speciosa L. and Cinnamomum burmanii L… Expand
Is this relevant?
2011
2011
Background: DLBS3233 is a standardized extract combination containing Lagerstroemia speciosa and Cinnamomum burmannii. The effect… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?